Best Practice & Research Clinical Endocrinology & Metabolism
Volume 23, Issue 6 , Pages 713-722, December 2009

Tyrosine kinase inhibitors and the thyroid

Department of Endocrine Neoplasia and Hormonal Disorders, Unit 1461, Division of Internal Medicine, The University of Texas M. D. Anderson Cancer Center, PO Box 301402, Houston, TX 77230-1402, USA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1521-690X(09)00082-7

doi:10.1016/j.beem.2009.08.001

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 23, Issue 6 , Pages 713-722, December 2009

Article Tools